SEARCH

SEARCH BY CITATION

References

  • Aarsand, A.K., Petersen, P.H. & Sandberg, S. (2006) Estimation and application of biological variation of urinary δ-aminolevulinic acd and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clinical Chemistry, 52, 650656.
  • Akagi, R., Nishitani, C., Harigae, H., Horie, Y., Garbaczewski, L., Hassoun, A., Mercelis, R., Verstraeten, L. & Sassa, S. (2000) Molecular analysis of δ-aminolevulinate dehydratase deficiency in a patient with an unusual late-onset porphyria. Blood, 96, 36183623.
  • Akagi, R., Kato, N., Inoue, R., Anderson, K.E., Jaffe, E.K. & Sassa, S. (2006) δ-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations. Molecular Genetics & Metabolism, 87, 329336.
  • Anderson, K.E., Spitz, I.M., Bardin, C.W. & Kappas, A. (1990a) A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. Archives of Internal Medicine, 150, 14691474.
  • Anderson, K.E., Goeger, D.E., Carson, R.W., Lee, S.M. & Stead, R.B. (1990b) Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis [published erratum appears in N Engl J Med 1990 May 31;322(22):1616]. New England Journal of Medicine, 322, 315317.
  • Anderson, K.E., Sassa, S., Bishop, D.F. & Desnick, R.J. (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: The Metabolic & Molecular Bases of Inherited Disease (ed. by C.R.Scriver, A.L.Beaudet, W.S.Sly & D.Valle), p. 2991. McGraw-Hill Medical Publishing Division, New York.
  • Anderson, K.E., Bonkovsky, H.L., Bloomer, J.R. & Shedlofsky, S.I. (2006) Reconstituion of hematin for intravenous infusion. Annals of Internal Medicine, 144, 537538.
  • Battersby, A.R., Fookes, C.J., Matcham, G.W. & McDonald, E. (1980) Biosynthesis of the pigments of life: formation of the macrocycle. Nature, 285, 1721.
  • Bechara, E.J. (1996) Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Brazilian Journal of Medical & Biological Research, 29, 841851.
  • Bergdahl, I.A., Grubb, A., Schutz, A., Desnick, R.J., Wetmur, J.G., Sassa, S. & Skerfving, S. (1997) Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacology & Toxicology, 81, 153158.
  • Bishop, D.F., Johansson, A., Phelps, R., Shady, A.A., Ramirez, M.C., Yasuda, M., Caro, A. & Desnick, R.J. (2006) Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype including the characteristic light-induced cutaneous lesions. American Journal of Human Genetics, 78, 645658.
  • Bonkovsky, H.L., Poh-Fitzpatrick, M., Pimstone, N., Obando, J., Di Bisceglie, A., Tattrie, C., Tortorelli, K., LeClair, P., Mercurio, M.G. & Lambrecht, R.W. (1998) Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology, 27, 16611669.
  • Brennan, M.J. & Cantrill, R.C. (1979) Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature, 280, 514515.
  • Brodie, M.J., Thompson, G.G., Moore, M.R., Beattie, A.D. & Goldberg, A. (1977) Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Quarterly Journal of Medicine, 46, 229241.
  • Christiansen, L., Bygum, A., Jensen, A., Brandrup, F., Thomsen, K., Horder, M. & Petersen, N.E. (2000) Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda. Scandinavian Journal of Clinical & Laboratory Investigation, 60, 611615.
  • Dean, G. (1982) Porphyria variegata. Acta Dermato-Venereologica.Supplementum (Stockh), 100, 8185.
  • Desnick, R.J., Glass, I.A., Xu, W., Solis, C. & Astrin, K.H. (1998) Molecular genetics of congenital erythropoietic porphyria. Seminars in Liver Disease, 18, 7784.
  • Doss, M.O., Stauch, T., Gross, V., Renz, M., Akagi, R., Doss-Frank, M., Seelig, H.P. & Sassa, S. (2004) The third case of doss porphyria (δ-aminolevulinic acid dehydratase deficiency) in Germany. Journal of Inherited Metabolic Disease, 27, 529536.
  • Egger, N.G., Goeger, D.E., Payne, D.A., Miskovsky, E.P., Weinman, S.A. & Anderson, K.E. (2002) Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Digestive Diseases & Sciences, 47, 419426.
  • Elder, G.H. (1998) Porphyria cutanea tarda. Seminars in Liver Disease, 18, 6775.
  • Elder, G.H. & Chapman, J.R. (1970) Isolation of a hydroxylated porphyrin from urine and faeces of patients with cutaneous hepatic porphyria. Biochimica et Biophysica Acta, 208, 535537.
  • Enriquez de Salamanca, R., Sepulveda, P., Moran, M.J., Santos, J.L., Fontanellas, A. & Hernandez, A. (1993) Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias. Clinical & Experimental Dermatology, 18, 128130.
  • Falk, J.E. (1964) Porphyrins and Metalloporphyrins, vol. 2. Elsevier, New York.
  • Fargion, S., Piperno, A., Cappellini, M.D., Sampietro, M., Fracanzani, A.L., Romano, R., Caldarelli, R., Marcelli, R., Vecchi, L. & Fiorelli, G. (1992) Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology, 16, 13221326.
  • Floderus, Y., Sardh, E., Moeller, C., Andersson, C., Rejkjaer, L., Andersson, D.E.H. & Harper, P. (2006) Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Clinical Chemistry, 52, 701707.
  • Fontanellas, A., Bensidhoum, M., Enriquez de Salamanca, R., Moruno, T.A., De Verneuil, H. & Ged, C. (1996) A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. European Journal of Human Genetics, 4, 274282.
  • Fritsch, C., Bolsen, K., Ruzicka, T. & Goerz, G. (1997) Congenital erythropoietic porphyria. Journal of the American Academy of Dermatology, 36, 594610.
  • Goldberg, A. (1959) Acute intermittent porphyria: a study of 50 cases. Quarterly Journal of Medicine, 28, 183209.
  • Gouya, L., Puy, H., Lamoril, J., Da Silva, V., Grandchamp, B., Nordmann, Y. & Deybach, J.C. (1999) Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood, 93, 21052110.
  • Granick, J.L., Sassa, S. & Kappas, A. (1978) Some biochemical and clinical aspects of lead intoxication. In: Advances in Clinical Chemistry (ed. by O.Bodansky and A.L.Latner), p. 287. Academic Press, New York.
  • Grossman, M.E., Bickers, D.R., Poh-Fitzpatrick, M.B., DeLeo, V.A. & Harber, L.C. (1979) Porphyria cutanea tarda: clinical features and laboratory findings in forty patients. American Journal of Medicine, 67, 277286.
  • Guarini, L., Piomelli, S. & Poh-Fitzpatrick, M.B. (1994) Hydroxyurea in congenital erythropoietic porphyria. New England Journal of Medicine, 330, 10911092.
  • Handschin, C., Lin, J., Rhee, J., Peyer, A.K., Chin, S., Wu, P.H., Meyer, U.A. & Spiegelman, B.M. (2005) Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell, 122, 505515.
  • Hassoun, A., Verstraeten, L., Mercelis, R. & Martin, J.-J. (1989) Biochemical diagnosis of an hereditary aminolaevulinate dehydratase deficiency in a 63-year-old man. Journal of Clinical Chemistry and Clinical Biochemistry, 27, 781786.
  • Hift, R.J., Meissner, D. & Meissner, P.N. (2004) A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family. British Journal of Dermatology, 151, 465471.
  • Ippen, H. (1977) Treatment of porphyria cutanea tarda by phlebotomy. Seminars in Hematology, 14, 253259.
  • Ishida, N., Fujita, H., Fukuda, Y., Noguchi, T., Doss, M., Kappas, A. & Sassa, S. (1992) Cloning and expression of the defective genes from a patient with δ-aminolevulinate dehydratase porphyria. Journal of Clinical Investigation, 89, 14311437.
  • Kauffman, L., Evans, D.I., Stevens, R.F. & Weinkove, C. (1991) Bone-marrow transplantation for congenital erythropoietic porphyria. Lancet, 337, 15101511.
  • Kauppinen, R. (2004) Molecular diagnostics of acute intermittent porphyria. Expert Review of Molecular Diagnostics, 4, 243249.
  • Kirsch, R.E., Meissner, P.N. & Hift, R.J. (1998) Variegate porphyria. Seminars in Liver Disease, 18, 3341.
  • Kordac, V. (1972) Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up. Neoplasma, 19, 135139.
  • Kuhnel, A., Gross, U. & Doss, M.O. (2000) Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients. Clinical Biochemistry, 33, 465473.
  • Lamola, A.A., Piomelli, S., Poh-Fitzpatrick, M.G., Yamane, T. & Harber, L.C. (1975) Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin. Journal of Clinical Investigation, 56, 15281535.
  • Lindberg, R.L., Porcher, C., Grandchamp, B., Ledermann, B., Burki, A., Brandner, S., Aguzzi, A. & Meyer, U.A. (1996) Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nature Genetics, 12, 195199.
  • Lindblad, B., Lindstedt, S. & Steen, G. (1977) On the genetic defects in hereditary tyrosinemia. Proceedings of the National Academy of Sciences, USA, 74, 46414645.
  • Lip, G.Y., McColl, K.E., Goldberg, A. & Moore, M.R. (1991) Smoking and recurrent attacks of acute intermittent porphyria. British Medical Journal, 302, 507507.
  • Litman, D.A. & Correia, M.A. (1985) Elevated brain tryptophan and enhanced 5-hydroxytryptamine turnover in acute hepatic heme deficiency: clinical implications. Journal of Pharmacology and Experimental Therpeutics, 232, 337345.
  • Martasek, P. (1998) Hereditary coproporphyria. Seminars in Liver Disease, 18, 2532.
  • Mathews-Roth, M.M., Pathak, M.A., Fitzpatrick, T.B., Harber, L.H. & Kass, E.H. (1977) Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Archives of Dermatology, 113, 12291232.
  • McManus, J.F., Begley, C.G., Sassa, S. & Ratnaike, S. (1996) Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria. Blood, 88, 35893600.
  • Meguro, K., Fujita, H., Ishida, N., Akagi, R., Kurihara, T., Galbraith, R.A., Kappas, A., Zabriskie, J.B., Toback, A.C., Harber, L.C. & Sassa, S. (1994) Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. Journal of Investigative Dermatology, 102, 681685.
  • Meissner, P.N., Dailey, T.A., Hift, R.J., Ziman, M., Corrigall, A.V., Roberts, A.G., Meissner, D.M., Kirsch, R.E. & Dailey, H.A. (1996) A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nature, 13, 9597.
  • Mendez, M., Sorkin, L., Rossetti, M.V., Astrin, K.H., Del C. Batlle, A.M., Parera, V.E., Aizencang, G. & Desnick, R.J. (1998) Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. American Journal of Human Genetics, 63, 13631375.
  • Meyer, U.A., Schuurmans, M.M. & Lindberg, R.L. (1998) Acute porphyrias: pathogenesis of neurological manifestations. Seminars in Liver Disease, 18, 4352.
  • Mueller, W.E. & Snyder, S.H. (1977) δ-Aminolevulinic acid: influences on synergistic GABA receptor binding may explain CNS symptoms of porphyria. Annals of Neurology, 2, 340342.
  • Mustajoki, P., Tenhunen, R., Pierach, C. & Volin, L. (1989) Heme in the treatment of porphyrias and hematological disorders. Seminars in Hematology, 26, 19.
  • Ostasiewicz, L.T., Huang, J.L., Wang, X., Piomelli, S. & Poh-Fitzpatrick, M.B. (1995) Human protoporphyria: genetic heterogeneity at the ferrochelatase locus. Photodermatology, Photoimmunology & Photomedicine, 11, 1821.
  • Peces, R., Enriquez de Salamanca, R., Fontanellas, A., Sanchez, A., De La Torre, M., Caparros, G., Ferreras, I. & Nieto, J. (1994) Successful treatment of haemodialysis-related porphyria cutanea tarda with erythropoietin. Nephrology, Dialysis, Transplantation, 9, 433435.
  • Piomelli, S., Poh-Fitzpatrick, M.B., Seaman, C., Skolnick, L.M. & Berdon, W.E. (1986) Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. New England Journal of Medicine, 314, 10291031.
  • Plewinska, M., Thunell, S., Holmberg, L., Wetmur, J.G. & Desnick, R.J. (1991) δ-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote. American Journal of Human Genetics, 49, 167174.
  • Poh-Fitzpatrick, M.B. (1984) Diagnosis and treatment of erythropoietic protoporphyria. Comprehensive Therapy, 10, 1217.
  • Poh-Fitzpatrick, M.B. & Lamola, A.A. (1976) Direct spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias. Journal of Laboratory & Clinical Medicine, 87, 362370.
  • Puy, H., Deybach, J.C., Bogdan, A., Callebert, J., Baumgartner, M., Voisin, P., Nordmann, Y. & Touitou, Y. (1996) Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat. Journal of Clinical Investigation, 97, 104110.
  • Roberts, A.G., Whatley, S.D., Morgan, R.R., Worwood, M. & Elder, G.H. (1997a) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet, 349, 321323.
  • Roberts, A.G., Whatley, S.D., Nicklin, S., Worwood, M., Pointon, J.J., Stone, C. & Elder, G.H. (1997b) The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology, 25, 159161.
  • Rocchi, E., Cassanelli, M., Gibertini, P., Pietrangelo, A., Casalgrandi, G. & Ventura, E. (1985) Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? Journal of Parenteral & Enteral Nutrition, 9, 447451.
  • Rodgers, P.A. & Stevenson, D.K. (1990) Developmental biology of heme oxygenase. Clinics in Perinatology, 17, 275291.
  • Sassa, S. (1996) Diagnosis and therapy of acute intermittent porphyria. Blood Reviews, 10, 5358.
  • Sassa, S. (2004) Understanding the porphyrias. In: UpToDate (ed. by B.D.Rose), pp. 16. UpToDate, Wellesley, MA.
  • Sassa, S. (2006a) The hematologic aspects of porphyria. In: Williams Hematology (ed. by M.A.Lichtman, E.Beutler, T.J.Kipps, U.Seligsohn, K.Kaushansky & J.T.Prchal), pp. 803822. McGraw-Hill, Inc., New York.
  • Sassa, S. (2006b) Porphyrias. In: Clinical Hematology (ed. by N.S.Young, S.L.Gerson & K.A.High), pp. 706720. Mosby Elsevier, Philadelphia, PA.
  • Sassa, S. & Kappas, A. (1983) Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of δ-aminolevulinic acid dehydratase activity by succinylacetone. Journal of Clinical Investigation, 71, 625634.
  • Soonawalla, Z.F., Orug, T., Badminton, M.N., Elder, G.H., Rhodes, J.M., Bramhall, S.R. & Elias, E. (2004) Liver transplantation as a cure for acute intermittent porphyria. Lancet, 363, 705706.
  • Stein, J.A. & Tschudy, D.P. (1970) Acute intermittent porphyria: a clinical and biochemical study of 46 patients. Medicine, 49, 116.
  • Tezcan, I., Xu, W., Gurgey, A., Tuncer, M., Cetin, M., Oner, C., Yetgin, S., Ersoy, F., Aizencang, G., Astrin, K.H. & Desnick, R.J. (1998) Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation. Blood, 92, 40534058.
  • Thomas, C., Ged, C., Nordmann, Y., De Verneuil, H., Pellier, I., Fischer, A. & Blanche, S. (1996) Correction of congenital erythropoietic porphyria by bone marrow transplantation. Journal of Pediatrics, 129, 453456.
  • Thunell, S., Holmberg, L. & Lundgren, J. (1987) Aminolevulinate dehydratase porphyria in infancy. A clinical and biochemical study. Journal of Clinical Chemistry and Clinical Biochemistry, 25, 514.
  • Tishler, P.V. & Winston, S.H. (1990) Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal. Methods & Findings in Experimental & Clinical Pharmacology, 12, 645648.
  • Todd, D.J. (1998) Molecular genetics of erythropoietic protoporphyria. Photodermatology, Photoimmunology & Photomedicine, 14, 7073.
  • Valls, V., Ena, J. & Enriquez de Salamanca, R. (1994) Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload. Journal of Dermatological Science, 7, 169175.
  • Waldenstrom, J. (1957) The porphyrias as inborn errors of metabolism. American Journal of Medicine, 22, 758773.
  • Watson, C.J. & Schwartz, S. (1941) A simple test for urinary porphobilinogen. Proceedings of Society for Experimental Biology and Medicine, 47, 393394.
  • Whatley, S.D., Puy, H., Morgan, R.R., Robreau, A.M., Roberts, A.G., Nordmann, Y., Elder, G.H. & Deybach, J.C. (1999) Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. American Journal of Human Genetics, 65, 984994.
  • Whetsell, W.O.J., Sassa, S. & Kappas, A. (1984) Porphyrin-heme biosynthesis in organotypic cultures of mouse dorsal root ganglia. Effects of heme and lead on porphyrin synthesis and peripheral myelin. Journal of Clinical Investigation, 74, 600607.
  • Yaqoob, M., Smyth, J., Ahmad, R., McClelland, P., Fahal, I., Kumar, K.A., Yu, R. & Verbov, J. (1992) Haemodialysis-related porphyria cutanea tarda and treatment by recombinant human erythropoietin. Nephron, 60, 428431.
  • Zix-Kieffer, I., Langer, B., Eyer, D., Acar, G., Racadot, E., Schlaeder, G., Oberlin, F. & Lutz, P. (1996) Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease). Bone Marrow Transplantation, 18, 217220.